Key result
Shear-targeted antithrombotics may inhibit arterial thrombosis without impairing hemostatic bleeding risk.
Why the study?
Distinct mechanisms of platelet aggregation under different shear stress conditions suggest the potential for lesion-specific antithrombotic therapies that inhibit arterial thrombosis without impairing hemostasis.
The paper proposes the conceptual basis for developing lesion-specific antithrombotic agents that target shear stress-induced platelet activation to inhibit arterial thrombosis without impairing hemostasis.
No takes yet. Share an insight, caveat, or question.
May require shear-specific antiplatelet approaches; leaves open whether current regimens address high-shear thrombosis adequately.
Kroll et al. (2005) conducted a review in Arterial thrombosis. Lesion-specific antiplatelet therapy was evaluated. Lesion-specific antithrombotic agents targeting shear stress-induced platelet activation are hypothesized to inhibit arterial thrombosis without causing bleeding from impaired hemostasis.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: